West Pharmaceutical Services, Inc. (WST): Price and Financial Metrics


West Pharmaceutical Services, Inc. (WST)

Today's Latest Price: $158.14 USD

3.16 (-1.96%)

Updated Apr 7 8:04pm

Add WST to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

WST Stock Summary

  • WST's went public 32.28 years ago, making it older than 89.12% of listed US stocks we're tracking.
  • The price/operating cash flow metric for West Pharmaceutical Services Inc is higher than 90.63% of stocks in our set with a positive cash flow.
  • In terms of volatility of its share price, WST is more volatile than only 5.06% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to West Pharmaceutical Services Inc, a group of peers worth examining would be ALGN, IAC, CARG, GMED, and BCPC.
  • Visit WST's SEC page to see the company's official filings. To visit the company's web site, go to www.westpharma.com.
WST Daily Price Range
WST 52-Week Price Range

WST Stock Price Chart More Charts


WST Price/Volume Stats

Current price $158.14 52-week high $176.66
Prev. close $161.30 52-week low $109.88
Day low $157.03 Volume 535,800
Day high $167.83 Avg. volume 511,990
50-day MA $153.79 Dividend yield 0.4%
200-day MA $145.32 Market Cap 11.68B

West Pharmaceutical Services, Inc. (WST) Company Bio


West Pharmaceutical Services develops, manufactures, and sells components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The company operates through two segments, Pharmaceutical Packaging Systems and Pharmaceutical Delivery Systems. The company was founded in 1923 and is based in Exton, Pennsylvania.

WST Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$158.14$84.27-48%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for West Pharmaceutical Services Inc. To summarize, we found that West Pharmaceutical Services Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for West Pharmaceutical Services Inc ended up being:

  • The company's debt burden, as measured by earnings divided by interest payments, is 36.38 -- which is good for besting 88.01% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet suggests that 3% of the company's capital is sourced from debt; this is greater than just 8.68% of the free cash flow producing stocks we're observing.
  • WST's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 58.16% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-49%
1%-48%
2%-48%
3%-47%
4%-47%
5%-46%

ENZ, ABT, VREX, ZBH, and BIO can be thought of as valuation peers to WST, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


WST Latest News Stream


Event/TimeNews Detail
Loading, please wait...

WST Latest Social Stream


Loading social stream, please wait...

View Full WST Social Stream

WST Price Returns

1-mo 13.12%
3-mo 4.52%
6-mo 11.61%
1-year 40.66%
3-year 102.07%
5-year 189.19%
YTD 5.30%
2019 54.13%
2018 -0.08%
2017 17.02%
2016 41.87%
2015 14.03%

WST Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full WST Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.866 seconds.